Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Litholink, a subsidiary of LabCorp, is a specialized medical laboratory and healthcare service provider focused on the prevention and management of kidney stones (nephrolithiasis). The company provides comprehensive 24-hour urine collection analysis and proprietary clinical decision support tools to help physicians identify metabolic risk factors. Their services include personalized reports that offer dietary and pharmacological recommendations tailored to a patient's specific biochemical profile. Beyond urology, Litholink also offers diagnostic solutions for bone health and chronic kidney disease management. By integrating laboratory data with clinical expertise, Litholink aims to reduce the recurrence of kidney stones and improve long-term patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Litholink.